Smith Hunter C bought RYTM
August 31, 2026 · Form 4 insider transaction
Smith Hunter C bought 57,187 shares of Rhythm Pharmaceuticals, Inc. at $25.79 per share, a transaction worth $1.47M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
57,187
Price
$25.79
Total value
$1.47M
InsiderSmith Hunter C
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 31, 2026
Filing dateSeptember 1, 2026
Shares owned after176,798
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The exercise and sales reported in this form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2026.